The mechanistic interplay between acetylation and ubiquitination is exemplified in colon cancer models, where acetylation of the K381/382 residues disrupts HDAC6-p53 complex formation and enhances transcriptional activity by unmasking p53’s DNA-binding domain, as demonstrated in prior studies [26]. Here, HDAC6 is linked to malignant colon neoplasm.